Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 29, 2026

Oct. 29, 2026

Ocugen to Participate in Upcoming November Investor and Industry Conferences

Indeterminate GlobeNewswire

Oct. 29, 2026

Novastra Therapeutics to Present First-in-Human Data for OAP-101 in Checkpoint-Refractory Advanced Melanoma at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Sironax Announces Three Abstracts on SARM1 Inhibitor SIR2501 Selected for Presentation at Neuroscience 2026

Indeterminate GlobeNewswire

Oct. 29, 2026

Indivior Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

维泰瑞隆宣布三篇关于SARM1抑制剂SIR2501的摘要入选2026年美国神经科学学会年会壁报展示

Indeterminate GlobeNewswire

Oct. 29, 2026

維泰瑞隆宣佈三篇關於SARM1抑制劑SIR2501的摘要入選2026年美國神經科學學會年會壁報展示

Indeterminate GlobeNewswire

Oct. 29, 2026

Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

Indeterminate GlobeNewswire

Oct. 29, 2026

C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders

Indeterminate GlobeNewswire

Oct. 29, 2026

BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Oct. 29, 2026

Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth

Indeterminate GlobeNewswire

Oct. 29, 2026

Ligand Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)

Indeterminate GlobeNewswire

Oct. 29, 2026

Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance

Indeterminate GlobeNewswire

Oct. 29, 2026

Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Oct. 29, 2026

Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations

Indeterminate GlobeNewswire

Oct. 29, 2026

Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences

Indeterminate GlobeNewswire

Oct. 29, 2026

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 29, 2026

Tilray Brands Announces Next Phase of Beverage Transformation

Indeterminate GlobeNewswire

Oct. 29, 2026

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026

Indeterminate GlobeNewswire